Accounts receivable, net of allowance of 55 and 27, respectively
53,074
Aco reach performance year receivable
321,596
Total current assets
639,882
Total assets
743,689
Medical costs payable
97,837
Short-term borrowings
1,000
Other current liabilities
70,362
Current liabilities of discontinued operations-Segment Discontinued Operations
333,799
Accounts payable
5,317
Warrant liability
27,651
Risk share payable to deconsolidated entity
123,981
Aco reach performance year obligation
248,465
Total current liabilities
908,412
Total long-term borrowings
212,433
Other liabilities
15,899
Total liabilities
1,136,744
Treasury stock, at cost, 31,526 shares at june30, 2025, and december31, 2024, respectively
12,000
Accumulated deficit
-4,464,323
Common stock, 0.0001 par value 3,000,000,000 shares authorized in 2025 and 2024 9,024,240 and 8,320,959 shares issued and outstanding in 2025 and 2024, respectively
1
Additional paid-in capital
3,107,121
Accumulated other comprehensive loss
0
Total shareholders equity (deficit)
-1,369,201
Redeemable series a and b preferred stock-Series BPreferred Stock
172,936
Redeemable series a and b preferred stock-Series APreferred Stock
747,481
Redeemable noncontrolling interests
55,729
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders equity (deficit)
743,689
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.